BDA MDI

COMBINATION_PRODUCT2 trials

Sponsors

Bond Avillion 2 Development LP, AstraZeneca

Conditions

Asthma

Phase 3

A Comparison of PT027 vs PT007 Used as Needed in Participants With Asthma

CompletedNCT05505734

Bond Avillion 2 Development LPAsthma

Start: 2022-09-02End: 2024-08-22Updated: 2025-08-03

Evaluating the Efficacy and Safety of PT027 Compared With PT007 Administered As Needed in Participants 12 to < 18 Years of Age With Asthma

RecruitingNCT06307665

AstraZenecaAsthma

Start: 2024-05-20End: 2027-10-13Target: 440Updated: 2026-08-13

Related Papers

Efficacy and safety of as-needed albuterol-budesonide versus albuterol in patients with asthma aged 12 to <18 years: design of the randomised, double-blind, parallel-group phase IIIb ACADIA trial.

2026-03-06

As-Needed Albuterol–Budesonide in Mild Asthma

New England Journal of Medicine2025-05-1912 citations

A Fully Decentralized Randomized Controlled Study of As-Needed Albuterol-Budesonide Fixed-Dose Inhaler in Mild Asthma: The BATURA Study Design.

2024-08-234 citations